High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

This study has been withdrawn prior to enrollment.
(There were no patient enrolled in this study at this site)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Hackensack University Medical Center
ClinicalTrials.gov Identifier:
NCT00447356
First received: March 12, 2007
Last updated: May 9, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given